Serial #98191516
LIVE

Serial Number

98191516

Owner

EMERGENT OPERATIONS IRELAND LIMITED

Attorney

Virginia Wolk Marino

First Use Date

Sep 23, 2023

Filing Date

Sep 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98191516 Trademark

Serial Number: 98191516 • Registration: 7740781

Serial #98191516 is a trademark filed by EMERGENT OPERATIONS IRELAND LIMITED on September 21, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EMERGENT OPERATIONS IRELAND LIMITED (32 trademarks)

6 EARLSFORT TERRACE
DUBLIN 2 , IE

Entity Type: 77

Trademark Details

Filing Date

September 21, 2023

Registration Date

March 25, 2025

First Use Anywhere

September 23, 2023

First Use in Commerce

September 23, 2023

Published for Opposition

March 19, 2024

Goods & Services

Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations

Online retail store services featuring opioid antagonists, narcotic antagonists and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose

Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 25, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 28, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 28, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 6, 2025 SUPC
USE AMENDMENT FILED
Feb 5, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 5, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 17, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2025 AITU
SOU EXTENSION 1 FILED
Nov 14, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 14, 2024 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 18, 2024 ASCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2024 CNSA
ASSIGNED TO EXAMINER
Feb 13, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 10, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2023 NWOS
NEW APPLICATION ENTERED
Sep 25, 2023 NWAP